- Home
- INGR vs CORT Comparison
INGR vs CORT Comparison
Compare INGR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGR
- CORT
- Stock Information
- Founded
- INGR 1906
- CORT 1998
- Country
- INGR United States
- CORT United States
- Employees
- INGR N/A
- CORT N/A
- Industry
- INGR Packaged Foods
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- INGR Consumer Staples
- CORT Health Care
- Exchange
- INGR Nasdaq
- CORT Nasdaq
- Market Cap
- INGR 8.0B
- CORT 8.8B
- IPO Year
- INGR 1997
- CORT N/A
- Fundamental
- Price
- INGR $120.97
- CORT $89.45
- Analyst Decision
- INGR Hold
- CORT Strong Buy
- Analyst Count
- INGR 6
- CORT 4
- Target Price
- INGR $147.83
- CORT $139.00
- AVG Volume (30 Days)
- INGR 622.8K
- CORT 940.0K
- Earning Date
- INGR 11-04-2025
- CORT 10-29-2025
- Dividend Yield
- INGR 2.63%
- CORT N/A
- EPS Growth
- INGR 4.50
- CORT N/A
- EPS
- INGR 10.23
- CORT 1.11
- Revenue
- INGR $7,316,000,000.00
- CORT $716,080,000.00
- Revenue This Year
- INGR $1.99
- CORT $30.77
- Revenue Next Year
- INGR $2.60
- CORT $37.75
- P/E Ratio
- INGR $11.90
- CORT $79.36
- Revenue Growth
- INGR N/A
- CORT 25.71
- 52 Week Low
- INGR $119.31
- CORT $42.01
- 52 Week High
- INGR $155.44
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- INGR 36.13
- CORT 77.61
- Support Level
- INGR $119.41
- CORT $82.70
- Resistance Level
- INGR $121.22
- CORT $90.71
- Average True Range (ATR)
- INGR 1.71
- CORT 2.28
- MACD
- INGR 0.02
- CORT 0.72
- Stochastic Oscillator
- INGR 23.59
- CORT 96.01
About INGR Ingredion Incorporated
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.